medigraphic.com
ISSN 2539-0859 (Electronic)
ISSN 0120-8411 (Print)
Asociación Colombiana de Otorrinolaringología y Cirugía de Cabeza y cuello, Maxilofacial y Estética Facial (ACORL)

2020, Number 3

<< Back Next >>

Acta de Otorrinolaringología CCC 2020; 48 (3)

Audiological and quality of life outcomes in patients with transition from BAHA Connect® to BAHA Attract®

Ordóñez-Ordóñez LE, Corredor-García GE, Vanegas SC, Angulo-Martínez ES

Language: Spanish
References: 27
Page: 218-225
PDF size: 238.18 Kb.


ABSTRACT

Introduction: the percutaneous bone-anchored hearing aid, has been successfully used. However, a significant number of patients report repetitive skin reactions. The transcutaneous bone-anchored hearing aid is an alternative that can solve these complications. With this study we aim to describe the audiological results and changes in the quality of life in patients who required transition from the percutaneous to the transcutaneous system. Methods: cross-sectional, descriptive observational study, patients with percutaneous hearing implants who required transition to the transcutaneous system were included. Hearing performance was assessed using a noisy background test and the quality of life scale Glasgow Benefit Inventory (GBI) was applied. Results: 8 patients were included, 3 of them with bilateral surgery, for 11 ears. The percutaneous implant was used on average = 9.5 ± 5.0 years, the reason for the transition was repetitive skin reactions. The auditory results show good performance, both in thresholds in silence = 37.1 ± 6.1 dB, and in speech recognition in noisy environment = 71.2% ± 19.8. These measures are significantly better than the results without implant, p ‹0.05. The signal/noise ratio was = -2.6 ± 2.7 dB. The results of the GBI scale showed a positive change, both in the overall result (median = +34.75), and in the three subscales (median; general state = +35.4, social relations = +41.65, physical health = +33.3). Conclusion: the transition from a percutaneous to a transcutaneous bone-anchored hearing aid can be performed safely and effectively. Satisfactory hearing performance was found with the use of the transcutaneous implant; as well as a positive change in the perception of quality of life.


REFERENCES

  1. Snik AF, Mylanus EA, Proops DW, Wolfaardt JF, Hodgetts WE,Somers T, et al. Consensus statements on the BAHA system:where do we stand at present?. Ann Otol Rhinol LaryngolSuppl. 2005;195:2-12. doi:10.1177/0003489405114s1201

  2. Verstraeten N, Zarowski AJ, Somers T, Riff D, Offeciers EF.Comparison of the audiologic results obtained with the boneanchoredhearing aid attached to the headband, the testband,and to the “snap” abutment. Otol Neurotol. 2009;30(1):70-75.doi:10.1097/MAO.0b013e31818be97a

  3. 3 Kruyt IJ, Bakkum KHE, Caspers CJI, Hol MKS. The efficacy ofbone-anchored hearing implant surgery in children: A systematicreview. Int J Pediatr Otorhinolaryngol. 2020;132:109906.doi:10.1016/j.ijporl.2020.109906

  4. Kim G, Ju HM, Lee SH, Kim HS, Kwon JA, Seo YJ. Efficacyof Bone-Anchored Hearing Aids in Single-Sided Deafness:A Systematic Review. Otol Neurotol. 2017;38(4):473-483.doi:10.1097/MAO.0000000000001359

  5. Dun CA, de Wolf MJ, Mylanus EA, Snik AF, Hol MK, CremersCW. Bilateral bone-anchored hearing aid application in children:the Nijmegen experience from 1996 to 2008. Otol Neurotol.2010;31(4):615-623. doi:10.1097/MAO.0b013e3181dbb37e

  6. Shapiro S, Ramadan J, Cassis A. BAHA Skin Complicationsin the Pediatric Population: Systematic Review With Metaanalysis.Otol Neurotol. 2018;39(7):865-873. doi:10.1097/MAO.0000000000001877

  7. Verheij E, Bezdjian A, Grolman W, Thomeer HG. A SystematicReview on Complications of Tissue Preservation SurgicalTechniques in Percutaneous Bone Conduction HearingDevices. Otol Neurotol. 2016;37(7):829-837. doi:10.1097/MAO.0000000000001091

  8. Dun CA, Faber HT, de Wolf MJ, Mylanus EA, Cremers CW, HolMK. Assessment of more than 1,000 implanted percutaneousbone conduction devices: skin reactions and implantsurvival. Otol Neurotol. 2012;33(2):192-198. doi:10.1097/MAO.0b013e318241c0bf

  9. Pross SE, Layton A, Tong K, Lustig LR. Cost of placement andcomplications associated with osseointegrated bone-conductinghearing prostheses: a retrospective analysis of medicarebilling data. Otol Neurotol. 2014;35(3):476-481. doi:10.1097/MAO.0b013e31829ce78d

  10. Holgers KM, Tjellström A, Bjursten LM, Erlandsson BE.Soft tissue reactions around percutaneous implants: a clinicalstudy of soft tissue conditions around skin-penetrating titaniumimplants for bone-anchored hearing aids. Am J Otol. 1988;9(1):56-9.

  11. Kiringoda R, Lustig LR. A meta-analysis of the complicationsassociated with osseointegrated hearing aids. Otol Neurotol.2013;34(5):790-794. doi:10.1097/MAO.0b013e318291c651

  12. de Wolf MJ, Hol MK, Huygen PL, Mylanus EA, CremersCW. Clinical outcome of the simplified surgical technique forBAHA implantation. Otol Neurotol. 2008;29(8):1100-1108.doi:10.1097/MAO.0b013e31818599b8

  13. Flynn M. Design concept and technological considerations forthe Cochlear BAHA 4 Attract System. Report E82744. 2013;1-7.

  14. Carr SD, Bruce IA, Jones D, Ray J. Outcomes followingconversion of a percutaneous to a transcutaneous boneconduction device in eight children. Clinical Otolaryngology.2017;42:917–20. doi: 10.1111/coa.12828

  15. Cedars E, Chan D, Lao A, Hardies L, Meyer A, Rosbe K.Conversion of traditional osseointegrated bone-anchoredhearing aids to the Baha® attract in four pediatric patients.Int J Pediatr Otorhinolaryngol. 2016;91:37-42. doi:10.1016/j.ijporl.2016.09.033

  16. Gawęcki W, Stieler OM, Balcerowiak A, Komar D, GibasiewiczR, Karlik M, Szyfter-Harris J, Wróbel M. Surgical, functionaland audiological evaluation of new Baha(®) Attract systemimplantations. Eur Arch Otorhinolaryngol. 2016;273(10):3123-30. doi: 10.1007/s00405-016-3917-5

  17. Iseri M, Orhan KS, Tuncer U, Kara A, Durgut M, GuldikenY, et al. Transcutaneous Bone-anchored Hearing Aids VersusPercutaneous Ones: Multicenter Comparative ClinicalStudy. Otol Neurotol. 2015;36(5):849-53. doi: 10.1097/MAO.0000000000000733

  18. Sanchez-Cuadrado I, Lassaletta L, Perez-Mora R, Muñoz E,Gavilan J. Reliability and validity of the Spanish GlasgowBenefit Inventory after cochlear implant surgery in adults. EurArch Otorhinolaryngol. 2015;272(2):333-336. doi:10.1007/s00405-013-2844-y

  19. Robinson K, Gatehouse S, Browning GG. Measuringpatient benefit from otorhinolaryngological surgery andtherapy. Ann Otol Rhinol Laryngol. 1996;105(6):415-422.doi:10.1177/000348949610500601

  20. Kraai T, Brown C, Neeff M, Fisher K. Complications ofbone-anchored hearing aids in pediatric patients. Int J PediatrOtorhinolaryngol. 2011;75(6):749-753. doi:10.1016/j.ijporl.2011.01.018

  21. Ordóñez-Ordóñez LE, Rey TG, Angulo-Martínez ES,Rodríguez SR, Vanegas SC and Guzmán Durán JE. Abstract:Clinical Experience with Sophono Alpha 2 MPO™ inConductive, Mixed and Sensorineural Hearing Losses Patients.J Otolaryngol ENT Res. 2017;9(2):00279. doi: 10.15406/joentr.2017.09.00279.

  22. Bezdjian A, Bruijnzeel H, Daniel SJ, Grolman W, ThomeerHGXM. Preliminary audiologic and peri-operative outcomesof the Sophono™ transcutaneous bone conduction device:A systematic review. Int J Pediatr Otorhinolaryngol.2017;101:196-203. doi:10.1016/j.ijporl.2017.08.014

  23. Zernotti ME, Di Gregorio MF, Galeazzi P, Tabernero P.Comparative outcomes of active and passive hearing devicesby transcutaneous bone conduction. Acta Otolaryngol.2016;136(6):556-558. doi:10.3109/00016489.2016.1143119

  24. Sharma S, Reddy-Kolanu G, Marshall AH. UK tertiary centreexperience of outcomes from osseointegrated transcutaneousmagnetic bone conduction hearing system implanted in twentyfivepatients using a linear incision technique. Clin Otolaryngol.2017;42(5):1041-1043. doi:10.1111/coa.12815

  25. Lau K, Scotta G, Wright K, Proctor V, Greenwood L, Dawoud M,et al. First United Kingdom experience of the novel Osia activetranscutaneous piezoelectric bone conduction implant. Eur ArchOto-Rhino-Laryngology. 2020. doi: 10.1007/s00405-020-06022-7

  26. Hendry J, Chin A, Swan IR, Akeroyd MA, Browning GG. TheGlasgow Benefit Inventory: a systematic review of the use andvalue of an otorhinolaryngological generic patient-recordedoutcome measure. Clin Otolaryngol. 2016;41(3):259-75. doi:10.1111/coa.12518.

  27. Arunachalam PS, Kilby D, Meikle D, Davison T, Johnson IJ.Bone-anchored hearing aid quality of life assessed by GlasgowBenefit Inventory. Laryngoscope. 2001;111(7):1260-1263.doi:10.1097/00005537-200107000-00022




2020     |     www.medigraphic.com